Neos is an investment manager with several strong, high-growth covered call ETFs. IYRI is one such ETF, focusing on REITs. It has similar characteristics to most covered call ETFs, namely a strong dis
CoStar Group (NASDAQ: CSGP - Get Free Report) and SecureAlert (OTCMKTS:TRCK - Get Free Report) are both computer and technology companies, but which is the superior investment? We will contrast the tw
Fast Track designation has the potential to facilitate development and accelerate FDA review of imdusiran WARMINSTER, Pa., April 15, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABU
KELLOGG, Idaho and VANCOUVER, British Columbia, April 15, 2026 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX: BNKR | OTCQB: BHLL) is pleased to provide a c
SOUTH SAN FRANCISCO, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”) a clinical stage biopharmaceutical company focused on improving patient outcomes
KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027 KT-621 BROADEN2 Phase 2b atopic dermatitis (AD) trial ongoing, with data expected by mid-2027 Fast Track de
In a Fast-Track SWIFT challenge brought by T-Mobile US, Inc., BBB National Programs' National Advertising Division determined that Verizon Communications Inc. provided adequate disclosure of a future
WELLESLEY HILLS, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, to
Archer Aviation is reiterated as a buy, with commercialization imminent and valuation at historically low levels. ACHR achieved a key FAA certification milestone, positioning it as a first mover with
The company said the FDA's Fast Track designation is intended to facilitate development and expedite regulatory review for drugs that treat serious conditions and address unmet medical needs.
FDA Fast Track designation supports accelerated development and expedites regulatory review Norovirus is responsible for an estimated 685 million global cases each year and approximately $60 billion i
Fast Track Designation highlights potential of CTIM-76 to address unmet need for patients with PROC CTIM-76 Phase 1a trial ongoing, with interim data expected in June 2026 PHILADELPHIA, April 02, 2026
MARYSVILLE, Ohio, April 02, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, announced that it i
OMAHA, Neb.--(BUSINESS WIRE)--Union Pacific Railroad and Amtrak announced they have reached an agreement that will allow Amtrak to operate on a 5-mile segment of Union Pacific-owned track starting nea
MIAMI, April 01, 2026 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE